Teneligliptin Hydrobromide
|
|
|
- CAS-Nr.
- 906093-29-6
- Englisch Name:
- Teneligliptin Hydrobromide
- Synonyma:
- Teneligliptin HydrobroMide Hydrate;Teneligliptin HBr;3-(((2s,4s)-4-(4-(3-Methyl-1-phenyl-1h-pyrazol-5-yl)-1-piperazinyl)-2-pyrrolidinyl)carbonyl)-thiazolidine hydrobromide (2:5) X H2O;API(Teneligliptin hydro bromide hydrate);3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-thiazolidine hydrobromide (2:5);[(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone,pentahydrobromide;MP-513 (hydrobromide);Ticagrelor hydrobromide;Tepagliptin (Hydrobromide);Teneligliptin (hydrobroMide)
- CBNumber:
- CB12666692
- Summenformel:
- C22H31BrN6OS
- Molgewicht:
- 507.5
- MOL-Datei:
- 906093-29-6.mol
|
Teneligliptin Hydrobromide Eigenschaften
- Schmelzpunkt:
- >211°C (dec.)
- storage temp.
- Refrigerator
- L?slichkeit
- Methanol (Slightly)
- Aggregatzustand
- Solid
- Farbe
- White to Light Beige
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H413 |
Kann für Wasserorganismen sch?dlich sein, mit langfristiger Wirkung. |
Langfristig (chronisch) gew?ssergef?hrdend |
Kategorie 4 |
|
|
|
|
| Sicherheit |
| P273 |
Freisetzung in die Umwelt vermeiden. |
| P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Teneligliptin Hydrobromide Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Teneligliptin Hydrobromide (2:5) is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. It is eliminated via excretion, and has a half-life of 24.2 hours in the human body.
Clinical Use
Teneligliptin is a DPP-4 inhibitor which was approved in Japan in 2012 for the treatment of type II
diabetes. It was discovered and developed by Mitsubishi Tanabe Pharma under the trade name
Tenelia®. Similar to other marketed DPP-4 inhibitors, teneligliptin was well tolerated in all studies and
QD dosing produced a long-lasting inhibitory action against DPP-4 and an increase in active GLP-1
levels, with very low rates of renal excretion.
Synthese
The only reported synthesis of teneligliptin is described in the scheme below. Reaction of commercially
available N-Boc-piperazine (158) with diketene (159) in DMF at room temperature gave acetoacetamide
160 in 86% yield, and this material was immediately condensed with phenylhydrazine in
methanesulfonic acid followed by a cyclodehydration with phosphorus oxychloride to give pyrazole 161
in 12% yield. The t-butyl carbamate was then removed with TFA in dichloromethane to give amine 162
in 88% yield. This amine was then subjected to butyrolactam 165 (which was prepared from N-Boctrans-
4-hydroxy-L-proline (163) coupled with thiazolidine (164) under conventional amide-forming
conditions using EDC) in the presence of sodium triacetoxy borohydride (STAB-H) in acetic acid.
This reductive amination reaction afforded the cis-aminopyrrolidine 166 exclusively in 50% yield.
Removal of the t-butyl carbamate group with TFA afforded the teneligliptin free amine in 93% yield,
and this freebase was then subsequently treated with 48% hydrobromic acid in refluxing ethanol to give
teleligliptin hydrobromide hydrate (XXV) in 90% yield.
Teneligliptin Hydrobromide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Teneligliptin Hydrobromide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 182)Lieferanten
- Teneligliptin (hydrobroMide)
- Teneligliptin HydrobroMide (2:5)
- MP-513 (hydrobromide)
- Teneligliptin hydrobromide anhydrous
- TENELIGLIPTIN HEMIPENTA HYDROBROMIDE HYDRATE
- ((2S)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone
- 3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piper...
- Teneligliptin hydrobromideQ: What is
Teneligliptin hydrobromide Q: What is the CAS Number of
Teneligliptin hydrobromide Q: What is the storage condition of
Teneligliptin hydrobromide Q: What are the applications of
Teneligliptin hydrobromide
- Teneligliptin Hydrobromide API
- Teneligliptin HydrobroMide Hydrate
- 3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-thiazolidine hydrobromide (2:5)
- Teneligliptin HBr
- [(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone,pentahydrobromide
- API(Teneligliptin hydro bromide hydrate)
- 3-(((2s,4s)-4-(4-(3-Methyl-1-phenyl-1h-pyrazol-5-yl)-1-piperazinyl)-2-pyrrolidinyl)carbonyl)-thiazolidine hydrobromide (2:5) X H2O
- Teneligliptin(hydrobromide)-amorphous
- Bis(((2S,4S)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone) pentahydrobromide
- Methanone, [(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinyl-, hydrobromide (2:5)
- (2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinyl-Methanone hydrobromide (2:5)
- Ticagrelor hydrobromide
- Teneligliptin HBr
[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]- 2-pyrrolidinyl]-3-thiazolidinylmethanone HBr
- Tepagliptin (Hydrobromide)
- 906093-29-6
- 2C22H30N6OS5HBr
- C44H65Br5N12O2S2
- 2C22H30N6OS5BrH
- API
